Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

From Receptor Structure to New Osteoporosis Drugs

20.11.2018

Researchers at the University of Zurich have determined the three-dimensional structure of a receptor that controls the release of calcium from bones. The receptor is now one of the main candidates for developing new drugs to treat osteoporosis. Knowing the receptor’s blueprint will be instrumental for designing drugs that could even help to rebuild bones.

Osteoporosis affects about 400,000 people in Switzerland, mostly women after menopause. It is often described as a silent disease, because bone loss usually occurs little by little over the years and without any symptoms.


The PTH-1 receptor consists of an extracellular part (purple) and a part that resides in the membrane (green). Parathyroid hormone (orange) activates the receptor.

University of Zurich

The body gradually absorbs calcium from the bones, which become brittle. This process is controlled via what is called the parathyroid hormone (PTH) and a closely related peptide – a protein fragment.

They bind to the PTH-1 receptor, thereby telling the body to either release calcium from the bone or to build new bone.

An extremely difficult undertaking

A team led by Andreas Plückthun, professor at the Department of Biochemistry of the University of Zurich (UZH), has now been able to determine the three-dimensional structure of the PTH-1 receptor.

The atomic structure can now serve as the blueprint for the future development of drugs. Such receptor-binding compounds may slow down, and perhaps even reverse, osteoporosis to some degree.

Determining the structure of this receptor was an extremely tough undertaking, as cells only produce a very small amount of it, and it is also very unstable.

“The directed evolution and protein engineering methods we have developed over the last few years were absolutely instrumental in making this possible,” explains Andreas Plückthun.

Disadvantages of current treatment

One of the most effective current treatments for severe osteoporosis involves the use of substances that look like the natural hormone and its related peptide.

“However, this treatment is extremely expensive. The substances have to be injected into the thigh or abdomen once a day, and the treatment also has significant side effects,” says Christoph Klenk, co-author of the study.

The scientists are convinced that thanks to the new insights into the mechanisms of the PTH-1 receptor, new drugs can be developed that don’t have any of the previous disadvantages.

“The receptor is like a lock, and the peptides are the keys that turn it,” describes Plückthun. “Having the atomic 3D blueprint on a computer screen gives us an unprecedented level of insight into how the lock actually works.”

Understanding a whole class of receptors

The PTH-1 receptor is a member of the family of G protein-coupled receptors. In particular, these include receptors that bind to other hormones, such as the ones involved in controlling diabetes.

The work by the UZH scientists thus also sheds light on how the whole family of receptors works, as the PTH-1 receptor was examined at the highest level of detail for any of these receptors so far.

This has enabled the scientists to describe similarities as well as differences to other class B receptors. “Having the blueprint of the lock doesn’t give us a key yet, but now it’s possible to build one,” says Andreas Plückthun.

Wissenschaftliche Ansprechpartner:

Prof. Andreas Plückthun, PhD
Department of Biochemistry
University of Zurich
Phone: +41 44 635 55 70
E-mail: plueckthun@bioc.uzh.ch

Originalpublikation:

Janosch Ehrenmann, Jendrik Schöppe, Christoph Klenk, Mathieu Rappas, Lutz Kummer, Andrew S. Doré, Andreas Plückthun. High-resolution crystal structure of parathyroid hormone 1 receptor in complex with a peptide agonist. Nature Structural and Molecular Biology, November 19, 2018. DOI: 10.1038/s41594-018-0151-4

Weitere Informationen:

https://www.media.uzh.ch/en/Press-Releases/2018/Osteoporosis.html

Kurt Bodenmüller | Universität Zürich
Further information:
http://www.uzh.ch/

More articles from Life Sciences:

nachricht A new molecular player involved in T cell activation
07.12.2018 | Tokyo Institute of Technology

nachricht News About a Plant Hormone
07.12.2018 | Julius-Maximilians-Universität Würzburg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers develop method to transfer entire 2D circuits to any smooth surface

What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.

Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...

Im Focus: Three components on one chip

Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.

Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...

Im Focus: Substitute for rare earth metal oxides

New Project SNAPSTER: Novel luminescent materials by encapsulating phosphorescent metal clusters with organic liquid crystals

Nowadays energy conversion in lighting and optoelectronic devices requires the use of rare earth oxides.

Im Focus: A bit of a stretch... material that thickens as it's pulled

Scientists have discovered the first synthetic material that becomes thicker - at the molecular level - as it is stretched.

Researchers led by Dr Devesh Mistry from the University of Leeds discovered a new non-porous material that has unique and inherent "auxetic" stretching...

Im Focus: The force of the vacuum

Scientists from the Theory Department of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science (CFEL) in Hamburg have shown through theoretical calculations and computer simulations that the force between electrons and lattice distortions in an atomically thin two-dimensional superconductor can be controlled with virtual photons. This could aid the development of new superconductors for energy-saving devices and many other technical applications.

The vacuum is not empty. It may sound like magic to laypeople but it has occupied physicists since the birth of quantum mechanics.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

Expert Panel on the Future of HPC in Engineering

03.12.2018 | Event News

Inaugural "Virtual World Tour" scheduled for december

28.11.2018 | Event News

 
Latest News

A new molecular player involved in T cell activation

07.12.2018 | Life Sciences

High-temperature electronics? That's hot

07.12.2018 | Materials Sciences

Supercomputers without waste heat

07.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>